Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1062

1.
2.

Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?

Abgral R, Querellou S, Potard G, Le Roux PY, Le Duc-Pennec A, Marianovski R, Pradier O, Bizais Y, Kraeber-Bodéré F, Salaun PY.

J Nucl Med. 2009 Jan;50(1):24-9. doi: 10.2967/jnumed.108.055806. Epub 2008 Dec 17.

3.
4.

Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.

Gourin CG, Watts TL, Williams HT, Patel VS, Bilodeau PA, Coleman TA.

Laryngoscope. 2008 Apr;118(4):671-5. doi: 10.1097/MLG.0b013e3181625737.

PMID:
18197136
5.

Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.

Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Sapir AE, Bar-Shalom R.

Pediatr Blood Cancer. 2007 Dec;49(7):901-5.

PMID:
17252575
6.
8.

Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer.

Gayed I, Vu T, Johnson M, Macapinlac H, Podoloff D.

Mol Imaging Biol. 2003 Jan-Feb;5(1):26-31.

PMID:
14499159
9.

Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.

Bastiaannet E, Wobbes T, Hoekstra OS, van der Jagt EJ, Brouwers AH, Koelemij R, de Klerk JM, Oyen WJ, Meijer S, Hoekstra HJ.

J Clin Oncol. 2009 Oct 1;27(28):4774-80. doi: 10.1200/JCO.2008.20.1822. Epub 2009 Aug 31.

PMID:
19720925
10.

PET monitoring of therapy response in head and neck squamous cell carcinoma.

Schöder H, Fury M, Lee N, Kraus D.

J Nucl Med. 2009 May;50 Suppl 1:74S-88S. doi: 10.2967/jnumed.108.057208. Epub 2009 Apr 20. Review.

11.

Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.

Tan A, Adelstein DJ, Rybicki LA, Saxton JP, Esclamado RM, Wood BG, Lorenz RR, Strome M, Carroll MA.

Arch Otolaryngol Head Neck Surg. 2007 May;133(5):435-40.

PMID:
17515501
12.

Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site.

Cianchetti M, Mancuso AA, Amdur RJ, Werning JW, Kirwan J, Morris CG, Mendenhall WM.

Laryngoscope. 2009 Dec;119(12):2348-54. doi: 10.1002/lary.20638.

PMID:
19718744
13.

Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.

Börjesson PK, Jauw YW, Boellaard R, de Bree R, Comans EF, Roos JC, Castelijns JA, Vosjan MJ, Kummer JA, Leemans CR, Lammertsma AA, van Dongen GA.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2133-40.

14.

Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.

Kim SY, Kim JS, Yi JS, Lee JH, Choi SH, Nam SY, Cho KJ, Lee SW, Kim SB, Roh JL.

Ann Surg Oncol. 2011 Sep;18(9):2579-84. doi: 10.1245/s10434-011-1655-x. Epub 2011 Mar 16.

PMID:
21409485
15.

[Role of PET-CT with 18-FDG in the management of UADT squamous-cell carcinomas: a retrospective study of 43 cases].

Ricard AS, Gindre A, Laurentjoye M, Fernandez P, Guyot M, Demeaux H, Siberchicot F, Majoufre-Lefebvre C.

Rev Stomatol Chir Maxillofac. 2008 Apr;109(2):86-90. doi: 10.1016/j.stomax.2007.11.002. Epub 2008 Jan 18. French.

PMID:
18207477
16.

Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of (18)F-FDG PET and extended-field multi-detector row CT.

Ng SH, Chan SC, Liao CT, Chang JT, Ko SF, Wang HM, Chin SC, Lin CY, Huang SF, Yen TC.

Neuroradiology. 2008 Nov;50(11):969-79. doi: 10.1007/s00234-008-0426-2. Epub 2008 Jul 4.

PMID:
18600319
17.
18.

In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit.

Wild D, Eyrich GK, Ciernik IF, Stoeckli SJ, Schuknecht B, Goerres GW.

J Craniomaxillofac Surg. 2006 Jan;34(1):9-16. Epub 2005 Dec 15.

PMID:
16343913
19.

Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.

Malone JP, Gerberi MA, Vasireddy S, Hughes LF, Rao K, Shevlin B, Kuhn M, Collette D, Tennenhouse J, Robbins KT.

Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1119-25. doi: 10.1001/archoto.2009.152.

PMID:
19917925
20.

Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.

Deron PB, Bonte KM, Vermeersch HF, Van de Wiele C.

Cancer Biother Radiopharm. 2011 Jun;26(3):331-4. doi: 10.1089/cbr.2010.0918. Epub 2011 Jun 28.

PMID:
21711095

Supplemental Content

Support Center